What's new? Log in Free sign up

Filing search / Lyell Immunopharma, Inc. / "Disability"

Search information

Lyell Immunopharma, Inc.

Companies

"Disability"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

45 results

Newest first Best match first

LYEL Lyell Immunopharma, Inc.

Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies

, inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant disability or incapacity, a congenital anomaly or birth … , employment discrimination, harassment, retaliation, disability rights or benefits, equal opportunity, plant closures and layoffs, affirmative action

LYEL Lyell Immunopharma, Inc.

Definitive proxy

-term disability, life and accidental death and dismemberment insurance for all of our employees, including our named executive officers. We generally … ) (excluding by reason of death or disability) or the Eligible Employee resigns for Good Reason (as defined below) (each, a “Qualifying Termination

22 Apr 24

4:15pm

LYEL Lyell Immunopharma, Inc.

Departure of Directors or Certain Officers

, as defined in the Company’s Officer Severance Plan; and (iii) the optionholder’s death or Disability (as defined in the applicable Plan). The Committee

LYEL Lyell Immunopharma, Inc.

Quarterly report

in the absence or disability of the President or whenever the office of President is vacant, unless the duties of the President are being filled by the Chief … officer to assume and perform the duties of the Secretary in the absence or disability of the Secretary, and each Assistant Secretary of the Corporation

7 Nov 23

4:14pm

LYEL Lyell Immunopharma, Inc.

Quarterly report

, unemployment, or disability benefits under applicable law; (ii) any rights to file an unfair labor practice charge under the National Labor Relations Act; (iii

8 Aug 23

4:21pm

Definitive proxy

27 Apr 23

4:06pm

Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer

Definitive proxy

Departure of Directors or Certain Officers

Registration of securities for employees

Registration of securities for employees

5k6hkhd4nun9cfki6i

Prospectus supplement with pricing info

IPO registration (amended)

IPO registration (amended)

rnbpz9xxwfltgsxz53m

IPO registration (amended)

lg8hvt5j46rzk5n20

IPO registration (amended)

IPO registration (amended)

IPO registration

IPO registration

Prev
1
2
3
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.